Literature DB >> 11751854

SH2-B family members differentially regulate JAK family tyrosine kinases.

Karen B O'Brien1, John J O'Shea, Christin Carter-Su.   

Abstract

Activation of JAK tyrosine kinases is an essential step in cell signaling by multiple hormones, cytokines, and growth factors, including growth hormone (GH) and interferon-gamma. Previously, we identified SH2-B beta as a potent activator of JAK2 (Rui, L., and Carter-Su, C. (1999) Proc. Natl. Acad. Sci. U.S.A. 96, 7172-7177). Here, we investigated whether the activation of JAK2 by SH2-B beta is specific to JAK2 and SH2-B beta or extends to other JAKs or other members of the SH2-B beta family. When SH2-B beta was overexpressed with JAK1 or JAK3, SH2-B beta failed to increase their activity. However, SH2-B beta bound to both and was tyrosyl-phosphorylated by JAK1. In contrast to SH2-B beta, APS decreased tyrosyl phosphorylation of GH-stimulated JAK2 as well as Stat5B, a substrate of JAK2. APS also decreased tyrosyl phosphorylation of JAK1, but did not affect the activity or tyrosyl phosphorylation of JAK3. Overexpressed APS bound to and was tyrosyl-phosphorylated by all three JAKs. Consistent with these data, in 3T3-F442A adipocytes, endogenous APS was tyrosyl-phosphorylated in response to GH and interferon-gamma. These results suggest that 1) SH2-B beta specifically activates JAK2, 2) APS negatively regulates both JAK2 and JAK1, and 3) both SH2-B beta and APS may serve as adapter proteins for all three JAKs independent of any role they have in JAK activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751854     DOI: 10.1074/jbc.M109165200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

Review 3.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 4.  What model organisms and interactomics can reveal about the genetics of human obesity.

Authors:  Michael J Williams; Markus S Almén; Robert Fredriksson; Helgi B Schiöth
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

Review 5.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

6.  Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.

Authors:  Jason H Kurzer; Pipsa Saharinen; Olli Silvennoinen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Regulation of lifespan, metabolism, and stress responses by the Drosophila SH2B protein, Lnk.

Authors:  Cathy Slack; Christian Werz; Daniela Wieser; Nazif Alic; Andrea Foley; Hugo Stocker; Dominic J Withers; Janet M Thornton; Ernst Hafen; Linda Partridge
Journal:  PLoS Genet       Date:  2010-03-19       Impact factor: 5.917

9.  Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses.

Authors:  Timothy Hoey; Shangming Zhang; Nathan Schmidt; Qing Yu; Shyam Ramchandani; Xiang Xu; Lisa K Naeger; Ya-Lin Sun; Mark H Kaplan
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

10.  The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway.

Authors:  Christian Werz; Katja Köhler; Ernst Hafen; Hugo Stocker
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.